# Avanos Medical

Avanos Medical is an Asset Manager based in Alpharetta, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Alpharetta, United States
- **Region:** North America
- **Address:** Alpharetta, GA, United States
- **Assets under management:** Undisclosed
- **Website:** avanos.com
- **LinkedIn:** https://www.linkedin.com/company/avanos-medical

## Regulatory record

- **Reports private funds:** No

## About

Avanos is a medical technology company that provides healthcare solutions focused on pain management & recovery and enteral feeding to help get patients back to what matters.

## Sectors

- Medical Devices
- Pain Management

## Offices

- Durham, NC
- Chicago, IL
- Raleigh, NC

## Questions

### What is the NOPAIN Act and why does it matter for Avanos?

The NOPAIN Act, passed in late 2022 and effective for Medicare outpatient procedures starting January 2024, provides separate reimbursement for non-opioid pain management devices that were previously bundled into the surgical payment. This removes the hospital's direct cost barrier for using Avanos's ON-Q and ambIT infusion pumps. CMS designation effectively positions these products as a new, reimbursable standard of care in the outpatient setting.

### Who runs Avanos Medical?

Joe Woody has served as CEO since the company's 2018 separation from Halyard Health. He previously led Halyard's medical device business and spent over two decades at Kimberly-Clark in various global roles. His tenure has been defined by portfolio streamlining — shedding non-core units like surgical and infection prevention, then respiratory health, to concentrate on pain management and enteral feeding.

### What is Avanos's largest product line?

The enteral feeding segment, which includes the MIC-KEY low-profile gastrostomy tube and CORTRAK placement system, generated the majority of 2023 revenue. Pain management and recovery products — led by ON-Q pumps and COOLIEF radiofrequency probes — represent the smaller, faster-growing segment, particularly with the NOPAIN Act reimbursement tailwind.

### Does Avanos invest in other companies or manage third-party capital?

No. Avanos uses its balance sheet solely for organic CapEx, R&D, and selective acquisitions of complementary product lines — such as the purchase of NeoMed's enteral portfolio in 2020. It has no disclosed fund vehicles, co-investment programs, or third-party asset management activities.

## Related profiles

- [Federal Group](https://altss.com/profile/federal-advisory-partners)
- [Parallax Energy Operating](https://altss.com/profile/parallax-energy-operating-inc)

---

Updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/avanos-medical

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology